Genomic structure of the PIK3CG gene on chromosome band 7q22 and evaluation as a candidate myeloid tumor suppressor

被引:28
作者
Kratz, CP
Emerling, BM
Bonifas, J
Wang, W
Green, ED
Le Beau, MM
Shannon, KM
机构
[1] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA
[2] St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA
[3] NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA
[4] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA
[5] Univ Chicago, Canc Res Ctr, Chicago, IL 60637 USA
关键词
D O I
10.1182/blood.V99.1.372
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PIK3CG, which encodes the catalytic subunit p110 gamma of phosphoinositide 3-OH-kinase-gamma (PI3K gamma), has been assigned to chromosome band 7q22, a region that is frequently deleted in myeloid malignancies. PI3K gamma -mutant mice have hematologic defects and are predisposed to colon cancer. On the basis of these data, PIK3CG was evaluated as a candidate myeloid tumor suppressor gene (TSG). PIK3CG was mapped by fluorescence in situ hybridization adjacent and telomeric to a commonly deleted segment defined previously in myeloid leukemias with breakpoints within 7q22. PIK3CG contains 10 exons and spans approximately 37 kilobases of genomic DNA. Forty leukemias with monosomy 7 or a del(7q) were screened for PIK3CG mutations. Two patients had missense variations affecting residue 859 in the N-terminal catalytic domain of the protein. This allele was also detected In unaffected parents and in 1 of 60 control alleles; It probably represents a polymorphism. PIK3CG Is unlikely to act as a recessive TSG In myeloid leukemias with monosomy 7. (Blood. 2002;99:372-374) (C) 2002 by The American Society of Hematology.
引用
收藏
页码:372 / 374
页数:3
相关论文
共 28 条
[1]   Aberrant methylation of gene promoters in cancer - Concepts, misconcepts, and promise [J].
Baylin, SB ;
Belinsky, SA ;
Herman, JG .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (18) :1460-1461
[2]   A new angle on a pervasive oncogene [J].
Cleary, ML .
NATURE GENETICS, 1999, 23 (02) :134-135
[3]  
Donovan JW, 2000, BLOOD, V95, P2651
[4]   The murine gene p27Kip1 is haplo-insufficient for tumour suppression [J].
Fero, ML ;
Randel, E ;
Gurley, KE ;
Roberts, JM ;
Kemp, CJ .
NATURE, 1998, 396 (6707) :177-180
[5]  
FISCHER K, 1997, BLOOD, V89, P2035
[6]   The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial [J].
Grimwade, D ;
Walker, H ;
Oliver, F ;
Wheatley, K ;
Harrison, C ;
Harrison, G ;
Rees, J ;
Hann, I ;
Stevens, R ;
Burnett, A ;
Goldstone, A .
BLOOD, 1998, 92 (07) :2322-2333
[7]   Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation [J].
Hirsch, E ;
Katanaev, VL ;
Garlanda, C ;
Azzolino, O ;
Pirola, L ;
Silengo, L ;
Sozzani, S ;
Mantovani, A ;
Altruda, F ;
Wymann, MP .
SCIENCE, 2000, 287 (5455) :1049-1053
[8]   TUMOR SPECTRUM ANALYSIS IN P53-MUTANT MICE [J].
JACKS, T ;
REMINGTON, L ;
WILLIAMS, BO ;
SCHMITT, EM ;
HALACHMI, S ;
BRONSON, RT ;
WEINBERG, RA .
CURRENT BIOLOGY, 1994, 4 (01) :1-7
[9]  
KALRA R, 1994, BLOOD, V84, P3435
[10]   CHROMOSOME-7 LONG-ARM DELETIONS IN MYELOID DISORDERS - TERMINAL DNA-SEQUENCES ARE COMMONLY CONSERVED AND BREAKPOINTS VARY [J].
KERE, J ;
DONISKELLER, H ;
RUUTU, T ;
DELACHAPELLE, A .
CYTOGENETICS AND CELL GENETICS, 1989, 50 (04) :226-229